Harvey Capital Management Inc Argenx Se Transaction History
Harvey Capital Management Inc
- $380 Million
- Q1 2025
A detailed history of Harvey Capital Management Inc transactions in Argenx Se stock. As of the latest transaction made, Harvey Capital Management Inc holds 11,075 shares of ARGX stock, worth $6 Million. This represents 1.72% of its overall portfolio holdings.
Number of Shares
11,075
Previous 11,561
4.2%
Holding current value
$6 Million
Previous $7.11 Million
7.82%
% of portfolio
1.72%
Previous 1.68%
Shares
4 transactions
Others Institutions Holding ARGX
# of Institutions
498Shares Held
28.5MCall Options Held
330KPut Options Held
286K-
Price T Rowe Associates Inc Baltimore, MD5.38MShares$2.92 Billion0.39% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI2.79MShares$1.51 Billion2.84% of portfolio
-
Janus Henderson Group PLC London, X02.14MShares$1.16 Billion0.73% of portfolio
-
Capital World Investors Los Angeles, CA1.94MShares$1.05 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY1.24MShares$670 Million11.83% of portfolio
About ARGENX SE
- Ticker ARGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,323,800
- Market Cap $30B
- Description
- argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...